Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras

Leukemia. 2016 May;30(5):1225-8. doi: 10.1038/leu.2015.293. Epub 2015 Oct 22.

Authors

P Liu¹, B Jiao¹, R Zhang¹, H Zhao¹, C Zhang¹, M Wu¹, D Li¹, X Zhao¹, Q Qiu¹, J Li¹, R Ren^{1

2}

Affiliations

¹ State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Collaborative Innovation Center of System Biology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Biology, Brandeis University, Waltham, MA, USA.

PMID: 26493479
DOI: 10.1038/leu.2015.293

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acyltransferases / antagonists & inhibitors*
Acyltransferases / genetics
Animals
Genes, ras*
Humans
Leukemia / genetics*
Mice
Mice, Knockout

Substances

Acyltransferases
ZDHHC9 protein, human